Therefore, also taking into consideration that its plasma levels are increased in primary aldosteronism and obesity [141,159,160,161], Gal-3 emerges as a novel circulating biomarker of cardiac damage and cardiometabolic disfunction due to MR activation. This evidence concerns the gene LGALS3 and Obesity.